tadalafil has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, S; Guo, L; Guo, Z; Han, L; Hou, N; Ling, R; Liu, S; Shi, C; Wang, T; Wang, Z; Wei, M; Wu, Y; Yan, B; Yao, L; Ye, J; Yi, J; Zhang, J; Zhao, H; Zhou, J; Zhou, W | 1 |
| Chen, S; Li, Z; Xiao, T; Yang, Z; Zhang, J | 1 |
2 other study(ies) available for tadalafil and Breast Cancer
| Article | Year |
|---|---|
PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.
Topics: Breast Neoplasms; Demethylation; Doxorubicin; Female; Humans; Protein-Arginine N-Methyltransferases; RNA; Tadalafil | 2022 |
Novel Chemicals Derived from Tadalafil Exhibit PRMT5 Inhibition and Promising Activities against Breast Cancer.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Doxorubicin; Enzyme Inhibitors; Female; Humans; Mice; Protein-Arginine N-Methyltransferases; Tadalafil | 2022 |